p>Treatment for cystic fibrosis (CF) has come along way—sixty years ago, most patients with cystic fibrosis didn’t live until puberty. Now they grow up, graduate, go to college, have careers, and raise families. New drugs now target the basic mechanism of the disease rather than the consequences, and even more effective treatments are in the pipeline.
Cystic fibrosis (or mucoviscidosis) is an inherited condition that reduces the water content of secretions within the body, causing thick and sticky mucus which fills up and blocks the lungs and other organs. It is one of the most common heritable genetic disorder in Caucasians in the US.
Cystic fibrosis is inherited from both parents. A person must have two cystic fibrosis genes, one from the father and one from the mother, to manifest. People with one cystic fibrosis gene are “carriers” but do not have cystic fibrosis.
Patients with cystic fibrosis produce a defective protein, called CFTR (cystic fibrosis transmembrane conductance regulator), which is normally embedded in cell membranes and transports chloride ions into and out of cells. Chlorine is one part of table salt, or sodium chloride. When the cell does not move chlorine out of the cell, sodium doesn’t leave, either, because it’s electrically attracted to the chlorine. Water wants to be where the salt is, so it stays with the sodium and chlorine. Because of this, tissues responsible for secretions do not include enough water, so the secretions are sticky, thick, and can block vital organs.
This is the basic mechanism responsible for cystic-fibrosis-related diseases throughout the body:
There are over 2000 genetic mutations that are responsible for cystic fibrosis. All are related to the CFTR protein. Based on the type of mutation, cystic fibrosis is divided into five classes of decreasing severity.
The first three classes are the most severe cases. Seven in ten CF patients are class 2 CF patients with a single common mutation, the F508 mutation.
Approximately 30,000 people in the United States (one in 11,000) have been diagnosed with CF. However, around 10 million people in the U.S. carry a cystic fibrosis gene. Risk factors for carrying a cystic fibrosis gene is limited to European descent or having relatives with cystic fibrosis.
The primary goal of treatment is to prevent and treat lung infections, maintain adequate nutrition, and manage other conditions as they arise. Patients born in 2018 can expect to live an average of 47 years, but life expectancy is more than 50 years in other countries.
Cystic fibrosis diagnosis begins at birth. All newborns in the United States are screened for cystic fibrosis along with other conditions using a blood test, the Newborn Screening Test. For cystic fibrosis, the test will measure the amount of a certain pancreatic protein called trypsinogen using IRT (immunoreactive trypsinogen test) and, depending on the state, genetic testing.
The average age for diagnosis is 6 months, but nearly all patients are diagnosed before the age of 2. A definitive diagnosis of CF consists of
Clinical evidence of CF could be a positive IRT test or a sibling with CF. If not, the doctor will monitor for clinical signs of cystic fibrosis in the infant including intestinal blockage, jaundice, lung problems, or poor weight gain.
Evidence of CFTR protein dysfunction includes the sweat chloride test, a DNA test, or other tests used if the results are ambiguous.
Patients with a defective CFTR protein do not reabsorb salt from the sweat before it leaves the body as other people do, so excessively salty sweat indicates a defective CFTR protein 99% of the time. Sweat chloride tests are accurate and inexpensive, so they are usually the first-line CFTR function test.
A sweat test might show higher than normal salt levels, but not high enough for a CF diagnosis. A DNA test will then be used that looks for at least two copies of a cystic fibrosis mutation. There must be one copy on both chromosomes. The disease usually does not manifest if only one mutated gene is present.
Neither the sweat test nor the DNA test is foolproof. There are over 2000 genetic mutations that cause cystic fibrosis, but DNA testing can only identify about 70 of the most common ones. To resolve questionable cases, one of two tests can measure the activity of the patient’s CFTR proteins by measuring voltage differences in the body’s tissues: the nasal potential difference (NPD) test and the intestinal current measurement (ICM).
Most patients will be treated by a team of healthcare professionals at clinics that specialize in cystic fibrosis. This team will include pulmonologists, gastroenterologists, endocrinologists, nutritionists, nurses, and physical therapists.
The centerpiece of CF treatment is to clear the lungs of mucus to prevent bacterial infection using physical therapy, exercise, and medications. Therapists and patients will regularly perform Airway Clearance Techniques (ACTs) involving inhaled mucus thinners followed by Chest Physical Therapy (CPT), such as striking the chest, coughing, vibration (a cystic fibrosis “vest”), or deep breathing techniques to bring the mucus out of the lungs.
Patients with CF are vulnerable to lung infections. Over time, serial lung infections damage the airways, reduce lung capacity, and eventually progress to lung failure. For this reason, doctors use a low threshold for lung infection diagnosis and hospitalize CF patients at the first sign of an acute infection. Infections are treated aggressively with oral and injected antibiotics, oxygenation, and airway clearance.
Pancreatic insufficiency means the digestive system is missing pancreatic enzymes that break down and aid the absorption of nutrients such as fat, proteins, and fat-soluble vitamins. CF patients require a high fat, high protein, and high-calorie diet as well as anywhere from 120% to 200% the normal RDA of vitamins and minerals. Oral pancreatic enzymes will be taken at meals to facilitate digestion and absorption.
Other conditions caused by cystic fibrosis, such as digestive problems, nasal and sinus problems, and liver problems, will be managed as they occur. The most serious are liver damage and cystic-fibrosis-related diabetes, both of which can reduce life expectancy.
Mutation-specific medications go to the source of cystic fibrosis and improve CFTR function. For now, however, CFTR modulator therapies only help supplement symptomatic treatment and are not a cure for cystic fibrosis.
Despite the best efforts of doctors, lung function will progressively decline and the lungs will eventually fail, requiring a lung transplant. The average life expectancy after lung transplantation is eight to nine years. Some CF patients may require a liver transplant because of progressive damage to the liver.
Most medications for cystic fibrosis treat or manage cystic-fibrosis-related diseases and conditions. They are effective at slowing down progressive damage to the lungs, organs, and other tissues in the body.
One of the primary goals of cystic fibrosis treatment is to clear mucus from the lungs using physical therapy combined with mucus thinners taken through an inhaler or nebulizer. Mucolytics, such as dornase alfa, break up substances in the mucus, making it less sticky and easier to expel. Secretolytics, such as inhaled hypertonic saline solution, make mucus more watery by drawing water out of the tissues and into the airways. The effects of mucus thinners are temporary, so cystic fibrosis patients need to perform physical airway clearance to clear the thinned mucus.
Bronchodilators, such as albuterol or ipratropium, increase the width of the airways to allow more airflow. These treatments help with breathing difficulties and improve shortness of breath.
The single greatest threat of cystic fibrosis is serial lung infections that over time steadily damage the lungs. Aggressive antibiotic therapy is used at the first sign of infection and includes penicillins, cephalosporins, azithromycin, tetracyclines, clindamycin, vancomycin, or sulfa drugs, among others.
Pancreatic insufficiency means that vital enzymes needed to digest and absorb nutrients are missing from the digestive system. Many CF patients need to take pancreatic enzymes at each meal to increase the digestion of foods and the absorption of fats, proteins, and nutrients by the intestines.
Cystic fibrosis patients need anywhere from 120% to 150% of the recommended daily allowance of vitamins to compensate for their lowered ability to digest and absorb nutrients. Fat-soluble (ADEK) vitamins are particularly important because CF patients often do not have enzymes that help transport fats across the intestinal walls. These vitamins are often taken as CF-specific multivitamins in a water-soluble format.
CFTR modulators directly address CFTR protein malfunction. Ivacaftor treats class 3 cystic fibrosis, which is caused by CFTR proteins on the cell membrane staying permanently closed. Ivacaftor is a “potentiator” that activates CFTR proteins and opens the chlorine channel. Lumacaftor, tezacaftor, and elexacaftor treat class 2 cystic fibrosis which is due to the malformation of the CFTR protein. These drugs are “correctors'' and are always combined with ivacaftor. They help fix the protein, move it to the cell membrane, and put it into place. Ivacaftor then activates the protein and opens the chlorine channel. These effects only last for as long as the drugs are in the bloodstream, so they must be taken regularly to be effective.
Cystic fibrosis affects systems and organs throughout the body, so many other types of drugs will be relied on to treat symptoms, such as anti-inflammatory medications, prokinetics to treat gastroesophageal reflux, laxatives for intestinal obstruction, bile acids for liver blockage, and insulin for diabetes.
Cystic fibrosis is a complex condition that affects organs and tissues throughout the body. Cystic fibrosis care involves a team effort of physicians and other healthcare providers who will find the right combination of medications and therapies suitable to the patient’s situation. Some of the most common drug classes used are represented in the table below.
Best medications for cystic fibrosis | ||||
---|---|---|---|---|
Drug Name | Drug Class | Administration Route | Standard Dosage | Common Side Effects |
Kalydeco (ivacaftor) | CFTR modulator | Oral | One 150 mg tablet every 12 hours | Headache, ear and throat pain, abdominal pain |
Trikafta (ivacaftor, tezacaftor, and elexacaftor) | CFTR modulator | Oral | Two tablets in the morning and one tablet in the evening | Headache, abdominal pain, diarrhea |
Pulmozyme (dornase alfa) | Mucolytic | Inhalant | One 2.5 ml of 1 mg/ml single-use ampule inhaled daily using a nebulizer | Decreased FVC (forced vital capacity), voice changes, throat swelling |
Hypertonic saline solution | Secretolytic | Inhalant | 4 ml of 3% or 7% solution nebulized twice daily | Sore throat, cough, chest tightness |
Atrovent HFA (ipratropium bromide) | Anticholinergic bronchodilator | Inhalant | Two inhalations four times a day | Upper respiratory tract infection, bronchitis, sinusitis |
Augmentin (amoxicillin-clavulanate) | Antibiotic | Oral | One 875-125 mg tablet every 12 hours | Diarrhea, nausea, skin rashes |
Zosyn (piperacillin-tazobactam) | Antibiotic | Oral | 50 ml of 3-0.375 grams every six hours | Diarrhea, headache, constipation |
Zithromax (azithromycin) | Antibiotic | Oral | Two 250 mg tablets on day 1 followed by one 250 mg tablet daily on days 2-5 | Diarrhea, nausea, abdominal pain |
Pancreaze (pancrelipase) | Pancreatic enzymes | Oral | 1,000-2,500 lipase units per kg. of body weight at each meal | Abdominal pain, flatulence, diarrhea |
Vitamax (ADEK) | Multivitamin | Oral | Follow the CFF guidelines for ADEK fat-soluble vitamin supplementation | Side effect 1, side effect 2, and side effect 3 |
Many of the standard dosages above are from the U.S. Food and Drug Administration (FDA). Dosage is determined by your doctor based on your medical condition, response to treatment, age, and weight. Other possible side effects exist. This is not a complete list.
Cystic fibrosis is a lifelong project that involves numerous medications of various types. Side effects will vary based on the medication, but the most serious issues are allergic reactions and drug interactions since more than one drug is often taken at a time. However, this is not a complete list, and you should consult with a healthcare professional for possible side effects and drug interactions based on your specific situation.
Headache is the most common side effect of CFTR modulators. Other side effects are breathing problems, nausea, and diarrhea. More seriously, CFTR modulators affect the liver function or increase blood pressure.
Inhaled mucus thinners are considered very safe. Side effects tend to result from irritation from the medicine such as sore throat, cough, runny nose, voice changes, or a bad taste in the mouth. The most serious side effects are allergic reactions to the ingredients.
Bronchodilators are classified as beta-2 agonists (albuterol) or anticholinergics (ipratropium). Beta-2 agonists tend to cause nervousness, heart palpitations, trembling, and muscle cramps, while the most common side effects of anticholinergics are dryness: dry mouth, dry eyes, or throat irritation. The most serious side effects of bronchodilators are high blood sugar or low potassium, but these effects are rare.
Antibiotics typically can cause gastrointestinal problems such as an upset stomach, intestinal problems, and loss of appetite. Allergic reactions are common and could be severe. Cystic fibrosis patients often take other medications, so drug interactions are a concern.
Pancreatic enzymes are naturally produced by the body, so side effects from oral pancreatic enzymes are fairly mild gastrointestinal complaints, such as gas, nausea, diarrhea, constipation, and bloating.
Cystic fibrosis is a lifetime project of protecting lung health, maintaining adequate levels of nutrition, and managing other conditions. Home treatment is an essential component of that project.
Your dietitian will recommend a daily regimen of three regular nutritious meals, regular snacks, CF-specific supplements, and pancreatic enzymes. Often times you will need a high-calorie diet.
It is especially important to drink fluids and replace electrolytes, particularly in warm weather.
Regular exercise helps strengthen the lungs and loosen mucus. Breathing exercises are also helpful.
Avoid smoke, invest in an air purifier, and keep surfaces and fabrics clean.
One of the most effective ways to reduce the risk of bacterial lung infections is to regularly wash the hands in soap and water.
Cystic fibrosis is a lifelong condition that affects organs throughout the body, particularly the lungs. Eventually, most patients will die of complications due to cystic fibrosis, usually end-stage lung disease. However, children born in 2018 can expect to live an average of 47-48 years with treatment. The oldest living patients with cystic fibrosis are in their early 80’s.
There are many promising therapies in research or clinical trials. Some involve gene therapy to correct the CFTR gene mutation. Currently, however, CF treatment largely focuses on conditions caused by cystic fibrosis.
Cystic fibrosis is an inherited condition that cannot be prevented.
Cystic fibrosis is a lifelong condition. It cannot be cured, but the symptoms can be managed. Many patients can complete school, have a career, get married, and maintain a fairly good quality of life.
Mucus thinners help to clear the airways to prevent infection, but they do not cure cystic fibrosis.
The foundational treatment of cystic fibrosis is to prevent lung infections through airway clearance, clear lung infections when they do occur, and ensure proper nutrition. Other conditions caused by cystic fibrosis are managed as they occur.
Medications treat the symptoms of cystic fibrosis, such as mucus-filled lungs, lung infections, pancreatic insufficiency, and other related problems. Some medications, called CFTR modulators, directly treat the cause of cystic fibrosis by correcting or activating CFTR proteins.
The primary conditions that require constant CF treatment are preventing and treating lung infections and pancreatic insufficiency. However, CF affects organs throughout the body and is responsible for other conditions such as cystic-fibrosis-related diabetes (CFRD), liver disease, enlarged spleen, gallbladder stones, nasal and sinus problems, bone loss, and male sterility. These conditions are treated with medications, physical therapy, and, sometimes, surgery, such as nasal polyp removal or liver transplant.
The long-term consequences of cystic fibrosis include progressive lung and liver damage. Most patients will experience end-stage lung disease that will require a lung transplant.
CF patients require a diet high in protein, fat, calories, and nutrients. There are no specific foods that cystic fibrosis nutritionists say should be avoided outright. However, the dietitian or nutritionist on the care team will recommend a diet tailored to the patient’s unique needs as well as instruct patients to avoid certain foods.
Current medical research is developing gene therapies that can correct the CFTR gene in various tissues in the body, such as the lungs. CFTR modulators continue to be developed that in combination can restore more normal CFTR function throughout the body.
Dr. Anis Rehman is an American Board of Internal Medicine (ABIM) certified physician in Internal Medicine as well as Endocrinology, Diabetes, and Metabolism who practices in Illinois. He completed his residency at Cleveland Clinic Akron General and fellowship training at University of Cincinnati in Ohio. Dr. Rehman has several dozen research publications in reputable journals and conferences. He also enjoys traveling and landscape photography. Dr. Rehman frequently writes medical blogs for District Endocrine (districtendocrine.com) and hosts an endocrine YouTube channel, District Endocrine.
...(Except Major Holidays)
© 2024 SingleCare Administrators. All Rights Reserved.
* Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price.
Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
This article is not medical advice. It is intended for general informational purposes and is not meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call your physician or dial 911.
This is a prescription discount plan. This is NOT insurance nor a Medicare prescription drug plan. The range of prescription discounts provided under this discount plan will vary depending on the prescription and pharmacy where the prescription is purchased and can be up to 80% off the cash price. You are fully responsible for paying your prescriptions at the pharmacy at the time of service, but you will be entitled to receive a discount from the pharmacy in accordance with the specific pre-negotiated discounted rate schedule. Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.Towers Administrators LLC (operating as 'SingleCare Administrators') is the authorized prescription discount plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services LLC ('SingleCare') is the vendor of the prescription discount plan, including their website.website at www.singlecare.com. For additional information, including an up-to-date list of pharmacies, or assistance with any problems related to this prescription drug discount plan, please contact customer service toll free at 844-234-3057, 24 hours a day, 7 days a week (except major holidays). By using the SingleCare prescription discount card or app, you agree to the SingleCare Terms and Conditions found at https://www.singlecare.com/terms-and-conditions
© 2024 SingleCare Administrators. All Rights Reserved.